Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2019. Start Trial.
Date Value
October 29, 2026 125.73M
October 28, 2026 122.36M
October 27, 2026 117.73M
October 26, 2026 116.05M
October 23, 2026 112.26M
October 22, 2026 113.94M
October 21, 2026 118.15M
October 20, 2026 115.20M
October 19, 2026 114.36M
October 16, 2026 119.84M
October 15, 2026 120.26M
October 14, 2026 120.68M
October 13, 2026 121.94M
October 12, 2026 124.05M
October 09, 2026 121.52M
October 08, 2026 111.83M
October 07, 2026 119.84M
October 06, 2026 119.63M
October 05, 2026 121.94M
October 02, 2026 119.84M
October 01, 2026 117.73M
September 30, 2026 115.62M
September 29, 2026 121.94M
September 28, 2026 117.73M
September 25, 2026 137.10M
Date Value
September 24, 2026 131.63M
September 23, 2026 136.68M
September 22, 2026 136.68M
September 21, 2026 135.00M
September 18, 2026 141.32M
September 17, 2026 140.05M
September 16, 2026 139.21M
September 15, 2026 137.10M
September 14, 2026 139.63M
September 11, 2026 134.58M
September 10, 2026 134.16M
September 09, 2026 140.89M
September 08, 2026 140.89M
September 04, 2026 140.89M
September 03, 2026 141.32M
September 02, 2026 142.16M
September 01, 2026 140.89M
August 31, 2026 140.89M
August 28, 2026 142.16M
August 27, 2026 138.79M
August 26, 2026 140.89M
August 25, 2026 143.42M
August 24, 2026 142.16M
August 21, 2026 143.84M
August 20, 2026 140.05M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Abbott Laboratories 208.60B
AngioDynamics, Inc. 500.71M
Alphatec Holdings, Inc. 2.245B
AtriCure, Inc. 3.084B
Baxter International, Inc. 18.83B